Jeremy Schenkein, MD
Pulmonary Disease · Mechanicsville, VANPI 1851319180
Payments from drug & device makers
Across 637 payments — averaging $178.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$101K
- AstraZeneca$2K
- Viiv Healthcare Company$2K
- Intuitive Surgical$1K
- Mylan Specialty L.p.$1K
- Medical Device Business Services, Inc.$975
- plus $6K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 199 | $100,847 |
| AstraZeneca | 91 | $1,825 |
| Viiv Healthcare Company | 1 | $1,600 |
| Intuitive Surgical | 5 | $1,199 |
| Mylan Specialty L.p. | 26 | $1,105 |
| Medical Device Business Services, Inc. | 4 | $975 |
| Boehringer Ingelheim | 41 | $846 |
| Sanofi | 36 | $749 |
| Novartis | 38 | $682 |
| Grifols USA, LLC | 21 | $428 |
| Insmed, Inc. | 22 | $401 |
| Amgen | 15 | $359 |
| Regeneron Healthcare Solutions, Inc. | 15 | $336 |
| Genentech USA, Inc. | 16 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $272 |
| Baxter Healthcare | 8 | $236 |
| Pfizer | 13 | $220 |
| Actelion Pharmaceuticals US, Inc. | 6 | $201 |
| United Therapeutics Corporation | 6 | $182 |
| Mallinckrodt Hospital Products Inc. | 7 | $142 |
| Paratek Pharmaceuticals, Inc. | 6 | $111 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pulmonx Corporation | 3 | $94 |
| Viatris Specialty LLC | 5 | $89 |
| Pharming Healthcare, Inc. | 5 | $87 |
| Electromed, Inc. | 6 | $85 |
| AbbVie | 4 | $82 |
| Vifor Pharma, Inc. | 4 | $74 |
| Johnson & Johnson(2 entities) | 4 | $69 |
| Philips North America LLC | 4 | $61 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Gilead | 3 | $41 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Verona Pharma, Inc. | 2 | $36 |
| Circassia Inc. | 2 | $30 |
| Merck | 1 | $19 |
| Inogen, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Advanced Respiratory, Inc | 1 | $12 |
How this compares
$114,014 in reported general payments places this provider in the 90th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Mechanicsville
- Drew JonesMechanicsville$16K
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Hannah MannemCharlottesville$326K
- Ray ShepherdRichmond$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.